Outcomes of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma and Deteriorating Liver Function

Background The treatment landscape for patients with unresectable hepatocellular carcinoma (uHCC) has recently expanded. However, there is an unmet need for effective treatment options in patients with Child-Pugh (CP) B liver function. Lenvatinib is ...